AS
Athena Saúde Brasil S.A. Stock: price and insider trades · Brazil
Athena Saúde Brasil S.A.: what insiders have been doing
Only a handful of insider records exist for Athena Saúde Brasil S.A., the last one from 10 August 2022, too few to describe a trend. Every figure here comes from the filings published by CVM (Brazil) and describes the past, not future prices; it is not investment advice.
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 1,158 of 26,911 companies
79.9
score / 100
Value63
Quality97
FCF yld11%
Earn yld6.3%
EV/EBITDA14.1x
ROE·
Gross mgn92%
Net mgn62%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
R$87.51
Analyst consensus
Income statement
RevenueR$48.1M
Gross profitR$44.1M92% margin
EBITDAR$33.2M69% margin
Net incomeR$29.6M61.6% margin
Valuation
PER (trailing)15.7x
Balance sheet & cash
Market capR$469.3M
Free Cash FlowR$49.3M
Profitability & ownership
% institutions0.1%
Last declaration on 10 August 2022
Declarations3 total
- 1,270,208 sharesOpções de Plano de RemuneraçãoB3CVM:31701408-bde5f7d4ca796b9e
- 555,864 sharesAçõesB3CVM:31701408-1696a48965faefe6
- 43,990 sharesAçõesB3CVM:31701408-c7736a5d9554e8b8
3 of 3 declarations
About Athena Saúde Brasil S.A.
Athena Saúde Brasil S.A. is a company operating in the healthcare and pharmaceutical sector, listed on the Brazilian Stock Exchange (BVMF). It focuses on providing innovative and quality healthcare services in Brazil.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations